⌘K

Longeveron Inc. (LGVN)

$2.10 2.44% $0.05 Healthcare

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Market cap

$30.08M

CEO

Dr. Joshua Michael Hare FACC, M.D.

Full time employees

18.00

Headquarters

Miami, FL

IPO Date

Feb 12, 2021

Price-to-earnings (PE) Ratio

-0.24

Earnings-per-share (EPS)

$-8.86

Cash ratio (TTM)

3.86

Current ratio (TTM)

4.18

Net profit margin (TTM)

-1,578.76%

PE ratio (TTM)

-0.67

PEG ratio (TTM)

0.00

Price-to-book ratio (TTM)

0.88

Price-to-sales ratio (TTM)

23.48

Quick ratio (TTM)

4.18

Return on assets (TTM)

-100.05%

Return on equity (TTM)

-246.98%

Similar stocks (20)

Edgewise Therapeutics, Inc.

EWTX

$29.77 56.11% $10.70

Uptrend

Keros Therapeutics, Inc.

KROS

$57.03 2.37% $1.32

Neutral

Erasca, Inc.

ERAS

$2.96 2.25% $0.06

Uptrend

C4 Therapeutics, Inc.

CCCC

$7.00 9.72% $0.62

Neutral

Larimar Therapeutics, Inc.

LRMR

$7.32 6.93% $0.48

Downtrend

Generation Bio Co.

GBIO

$2.81 8.49% $0.22

Downtrend

Nutriband Inc.

NTRB

$6.06 19.39% $0.98

Neutral

Kronos Bio, Inc.

KRON

$0.95 3.23% $0.03

Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 0.57% $0.00

Downtrend

Surrozen, Inc.

SRZN

$8.10 1.12% $0.09

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.64 3.57% $0.02

Downtrend

RenovoRx, Inc.

RNXT

$0.97 -2.03% $-0.02

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.53 8.51% $0.12

Downtrend

Kiora Pharmaceuticals, Inc.

KPRX

$3.67 1.38% $0.05

Downtrend

Forte Biosciences, Inc.

FBRX

$7.07 5.05% $0.34

Downtrend

ABVC BioPharma, Inc.

ABVC

$0.66 0.00% $0.00

Downtrend

Pasithea Therapeutics Corp.

KTTA

$5.19 -10.54% $-0.61

Downtrend

Revelation Biosciences, Inc.

REVB

$0.87 0.46% $0.00

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.56 -2.91% $-0.02

Downtrend

Better Therapeutics, Inc.

BTTX

$0.00 0.00% $0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend

Downtrend

Similar stocks (20)

Edgewise Therapeutics, Inc.

EWTX

$29.77 56.11% $10.70

Uptrend

Keros Therapeutics, Inc.

KROS

$57.03 2.37% $1.32

Neutral

Erasca, Inc.

ERAS

$2.96 2.25% $0.06

Uptrend

C4 Therapeutics, Inc.

CCCC

$7.00 9.72% $0.62

Neutral

Larimar Therapeutics, Inc.

LRMR

$7.32 6.93% $0.48

Downtrend

Generation Bio Co.

GBIO

$2.81 8.49% $0.22

Downtrend

Nutriband Inc.

NTRB

$6.06 19.39% $0.98

Neutral

Kronos Bio, Inc.

KRON

$0.95 3.23% $0.03

Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 0.57% $0.00

Downtrend

Surrozen, Inc.

SRZN

$8.10 1.12% $0.09

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.64 3.57% $0.02

Downtrend

RenovoRx, Inc.

RNXT

$0.97 -2.03% $-0.02

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.53 8.51% $0.12

Downtrend

Kiora Pharmaceuticals, Inc.

KPRX

$3.67 1.38% $0.05

Downtrend

Forte Biosciences, Inc.

FBRX

$7.07 5.05% $0.34

Downtrend

ABVC BioPharma, Inc.

ABVC

$0.66 0.00% $0.00

Downtrend

Pasithea Therapeutics Corp.

KTTA

$5.19 -10.54% $-0.61

Downtrend

Revelation Biosciences, Inc.

REVB

$0.87 0.46% $0.00

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.56 -2.91% $-0.02

Downtrend

Better Therapeutics, Inc.

BTTX

$0.00 0.00% $0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend